Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.

SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of ...

The CeliacDx offering for Texas marks the company’s first outreach to physicians with additional states planned for later this year. The expansion into physician-ordered testing furthers Targeted ...

Aurora-based Children’s Hospital Colorado has opened an in-house genomics testing lab through its Precision Medicine Institute. The lab enables genomic testing results to be more quickly integrated ...

Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...

(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY ® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD ...

Every year, 20,000 genetic tests are sent to laboratories in the UK, US, Germany, Spain and Finland - senators want to bring that testing back to Ireland ...

On March 12th, the Saudi National Unified Procurement Company (NUPCO) officially announced the bidding results for the three-year centralized procurement project for outsourced testing services for ...